265 related articles for article (PubMed ID: 21151598)
1. Molecular characterization of the 5'-UTR of retinal dystrophin reveals a cryptic intron that regulates translational activity.
Kubokawa I; Takeshima Y; Ota M; Enomoto M; Okizuka Y; Mori T; Nishimura N; Awano H; Yagi M; Matsuo M
Mol Vis; 2010 Dec; 16():2590-7. PubMed ID: 21151598
[TBL] [Abstract][Full Text] [Related]
2. Neuronal SH-SY5Y cells use the C-dystrophin promoter coupled with exon 78 skipping and display multiple patterns of alternative splicing including two intronic insertion events.
Nishida A; Minegishi M; Takeuchi A; Awano H; Niba ET; Matsuo M
Hum Genet; 2015 Sep; 134(9):993-1001. PubMed ID: 26152642
[TBL] [Abstract][Full Text] [Related]
3. A novel cryptic exon identified in the 3' region of intron 2 of the human dystrophin gene.
Tran VK; Zhang Z; Yagi M; Nishiyama A; Habara Y; Takeshima Y; Matsuo M
J Hum Genet; 2005; 50(8):425-433. PubMed ID: 16133659
[TBL] [Abstract][Full Text] [Related]
4. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.
van Deutekom JC; Bremmer-Bout M; Janson AA; Ginjaar IB; Baas F; den Dunnen JT; van Ommen GJ
Hum Mol Genet; 2001 Jul; 10(15):1547-54. PubMed ID: 11468272
[TBL] [Abstract][Full Text] [Related]
5. Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy.
Tuffery-Giraud S; Saquet C; Chambert S; Claustres M
Hum Mutat; 2003 Jun; 21(6):608-14. PubMed ID: 12754707
[TBL] [Abstract][Full Text] [Related]
6. In vitro splicing analysis showed that availability of a cryptic splice site is not a determinant for alternative splicing patterns caused by +1G-->A mutations in introns of the dystrophin gene.
Habara Y; Takeshima Y; Awano H; Okizuka Y; Zhang Z; Saiki K; Yagi M; Matsuo M
J Med Genet; 2009 Aug; 46(8):542-7. PubMed ID: 19001018
[TBL] [Abstract][Full Text] [Related]
7. Structural organization and expression pattern of the canine RPGRIP1 isoforms in retinal tissue.
Kuznetsova T; Zangerl B; Goldstein O; Acland GM; Aguirre GD
Invest Ophthalmol Vis Sci; 2011 May; 52(6):2989-98. PubMed ID: 21282582
[TBL] [Abstract][Full Text] [Related]
8. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
9. Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.
Zhang Z; Habara Y; Nishiyama A; Oyazato Y; Yagi M; Takeshima Y; Matsuo M
J Hum Genet; 2007; 52(7):607-617. PubMed ID: 17579806
[TBL] [Abstract][Full Text] [Related]
10. Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping.
Bertoni C; Lau C; Rando TA
Hum Mol Genet; 2003 May; 12(10):1087-99. PubMed ID: 12719373
[TBL] [Abstract][Full Text] [Related]
11. Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity.
Raevskaya NM; Dergunova LV; Vladychenskaya IP; Stavchansky VV; Oborina MV; Poltaraus AB; Limborska SA
Gene; 2005 Oct; 359():127-37. PubMed ID: 16162394
[TBL] [Abstract][Full Text] [Related]
12. Novel cryptic exons identified in introns 2 and 3 of the human dystrophin gene with duplication of exons 8-11.
Ishibashi K; Takeshima Y; Yagi M; Nishiyama A; Matsuo M
Kobe J Med Sci; 2006; 52(3-4):61-75. PubMed ID: 16849873
[TBL] [Abstract][Full Text] [Related]
13. Heterogous dystrophin mRNA produced by a novel splice acceptor site mutation in intermediate dystrophinopathy.
Adachi K; Takeshima Y; Wada H; Yagi M; Nakamura H; Matsuo M
Pediatr Res; 2003 Jan; 53(1):125-31. PubMed ID: 12508091
[TBL] [Abstract][Full Text] [Related]
14. Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5' mutation hot spot of the dystrophin gene.
Gualandi F; Rimessi P; Trabanelli C; Spitali P; Neri M; Patarnello T; Angelini C; Yau SC; Abbs S; Muntoni F; Calzolari E; Ferlini A
Gene; 2006 Mar; 370():26-33. PubMed ID: 16439068
[TBL] [Abstract][Full Text] [Related]
15. Identification of the shortest splice variant of Dp71, together with five known variants, in glioblastoma cells.
Rani AQM; Farea M; Maeta K; Kawaguchi T; Awano H; Nagai M; Nishio H; Matsuo M
Biochem Biophys Res Commun; 2019 Jan; 508(2):640-645. PubMed ID: 30527806
[TBL] [Abstract][Full Text] [Related]
16. A G-to-A transition at the fifth position of intron-32 of the dystrophin gene inactivates a splice-donor site both in vivo and in vitro.
Thi Tran HT; Takeshima Y; Surono A; Yagi M; Wada H; Matsuo M
Mol Genet Metab; 2005 Jul; 85(3):213-9. PubMed ID: 15979033
[TBL] [Abstract][Full Text] [Related]
17. A novel cryptic exon in intron 3 of the dystrophin gene was incorporated into dystrophin mRNA with a single nucleotide deletion in exon 5.
Suminaga R; Takeshima Y; Adachi K; Yagi M; Nakamura H; Matsuo M
J Hum Genet; 2002; 47(4):196-201. PubMed ID: 12166656
[TBL] [Abstract][Full Text] [Related]
18. Insertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy.
Narita N; Nishio H; Kitoh Y; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
J Clin Invest; 1993 May; 91(5):1862-7. PubMed ID: 8387534
[TBL] [Abstract][Full Text] [Related]
19. A novel cryptic exon in intron 2 of the human dystrophin gene evolved from an intron by acquiring consensus sequences for splicing at different stages of anthropoid evolution.
Dwi Pramono ZA; Takeshima Y; Surono A; Ishida T; Matsuo M
Biochem Biophys Res Commun; 2000 Jan; 267(1):321-8. PubMed ID: 10623618
[TBL] [Abstract][Full Text] [Related]
20. Intronic Alternative Polyadenylation in the Middle of the
Rani AQM; Yamamoto T; Kawaguchi T; Maeta K; Awano H; Nishio H; Matsuo M
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
